aspirin
Research roundup
Debbie Rigby examines the latest research news Faecal microbiota transplantation for recurrent Clostridum difficile infection Faecal microbiota transplantation (FMT) has become routine in managing recurrent C. difficile infection (CDI) refractory …
Australia’s largest clinical trial to share in millions
Trial of daily aspirin use for disease prevention in older Australians will receive part of $483 million in grants for health and medical research announced by the Minister for Health …
Weekly Dose: aspirin, the pain and fever reliever that prevents heart attacks, strokes and maybe cancer
Weekly Dose: aspirin, the pain and fever reliever that prevents heart attacks, strokes and maybe cancer Andrew Tonkin, Monash University Aspirin is, like ibuprofen and Voltaren (diclofenac), a non-steroidal anti-inflammatory …
Research Roundup
Debbie Rigby takes a look at the latest research pertinent to community pharmacy Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes In this double-blind trial, liraglutide, an analogue of human …
Research Roundup
Debbie Rigby presents the latest research news relevant to pharmacy Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease Evidence from a total of 11 trials involving more than 118,000 patients …
Monash Uni to investigate whether aspirin could help heal leg ulcers
Researchers from Monash University are set to examine whether aspirin can improve the healing rates of leg ulcers in older adults.
Aspirin pricing reports misleading: Guild
News reports on aspirin pricing are misleading, says the Guild: some news reports of the ANAO audit of the Administration of the Fifth Community Pharmacy Agreement have referred to the …